Archive

Neovasc Announces US$6.1 Million Registered Direct Offering Priced At-the-Market

VANCOUVER and MINNEAPOLIS, MN - (NewMediaWire) - December 08, 2020 - Neovasc, Inc.("Neovasc" or the "Company") (NASDAQ,TSX: NVCN) announced today that it has entered into definitive agreements with certain healthcare-focused institutional investors for the sale of an aggregate of 6,230,803 common shares at a purchase...

Read More

Neovasc Announces Third Quarter Financial Results

VANCOUVER and MINNEAPOLIS - (NewMediaWire) - November 05, 2020 - Neovasc, Inc.(NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company"), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies, and minimally invasive devices for the treatment of refractory angina, today reported financial...

Read More

Neovasc to Report Third Quarter Financial Results on November 5, 2020

VANCOUVER and MINNEAPOLIS - (NewMediaWire) - October 22, 2020 - Neovasc, Inc.(NASDAQ,TSX: NVCN) today announced that it will report financial results for the quarter ended September 30, 2020 after the market close on November 5, 2020. Neovasc President and Chief Executive Officer Fred Colen, and...

Read More

Neovasc to Participate in H.C. Wainwright & Co. 22nd Annual Global Investment Conference

VANCOUVER and MINNEAPOLIS - (NewMediaWire) - September 08, 2020 - Neovasc, Inc.("Neovasc" or the "Company") (NASDAQ,TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies, and minimally invasive devices for the treatment of refractory angina, today announced that its management team will be participating...

Read More